Skip to main content
Search
Newsletters
Watchlist
Home
Watchlist
For You
Canada
World
Business
Investing
Personal Finance
Opinion
Politics
Sports
Life
Arts
Drive
Real Estate
Latest in
Subscribe
Digital access
Digital + home delivery
TSX
0.1%
S&P 500
-0.67%
DOW
-0.61%
NASDAQ
-1%
Oil
0.26%
Dollar
0.3%
Gold
-0.78%
tsx movers:
MFC-T
-0.26%
WCP-T
+2.83%
TD-T
+0.11%
ENB-T
+0.96%
Instrument Name
Replicel Life Sciences Inc
Instrument Symbol
(RP-X)
Instrument Exchange
TSX Venture
Add to Watchlist
Create Alerts
CAD
Today's Change
Delayed
Last Update
CAD
After Hours
Change
After Hours
Last Update
After Hours
Price
Volume
Summary
Charts
Profile
Financials
Statistics
Dividends
Price History
Analyst Estimates
Insiders
Next Dividend
Data
Most Recent Dividend
Dividend Rate
Dividend Reinvestment Plan
Split
Currency in CAD
Rates & Yield
Forward Annual Rate
Forward Annual Yield
Trailing Annual Rate
Trailing Annual Yield
Payout Ratio
Historical Dividends & Split
Dividends
Splits
More from The Globe
opinion
You think that BCE is a loser. But is it really?
Tom Bradley
May 24, 2025
Hydro One is a hot stock. Is it too hot?
David Berman
May 23, 2025
number cruncher
Dependable dividend payers that helped the CPP bolster its returns
May 22, 2025
Bullish on Quebecor Inc.
Monica Rizk
May 22, 2025
Thursday’s analyst upgrades and downgrades
May 22, 2025
Tuesday’s analyst upgrades and downgrades
May 20, 2025
analysis
The decline of BCE sparks a question: What counts as a blue-chip stock?
Norman Rothery
May 20, 2025
opinion
Dig deeper, and you’ll see that value stocks often do actually outperform
George Athanassakos
May 19, 2025